Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission

Masatoshi Sakurai, Shintaro Watanuki, Jun Kato, Risa Hashida, Yusuke Yamane, Daiki Karigane, Takayuki Mitsuhashi, Mitsuru Murata, Hironori Ueno, Tomonori Nakazato, Shinichiro Okamoto, Takehiko Mori

Research output: Contribution to journalArticle

Abstract

The prognosis of acute promyelocytic leukemia (APL) has been improved by the combination of all-trans retinoic acid (ATRA) with chemotherapy. Nonetheless, relapse occurs in a certain proportion of patients, mostly within three to four years after treatment. We herein report a patient treated with ATRA and chemotherapy achieving remission who relapsed approximately 17 years after the treatment. A literature review identified 5 additional reported cases of APL relapse after more than 10 years. None of them presented with generally established risk factors for relapse, such as a high leukocyte count. The potential for late relapse of APL occurring more than 10 years after treatment should be recognized.

Original languageEnglish
Pages (from-to)3299-3302
Number of pages4
JournalInternal medicine (Tokyo, Japan)
Volume57
Issue number22
DOIs
Publication statusPublished - 2018 Nov 15

Fingerprint

Acute Promyelocytic Leukemia
Recurrence
Tretinoin
Drug Therapy
Leukocyte Count
Therapeutics

Keywords

  • acute promyelocytic leukemia
  • all-trans retinoic acid
  • late relapse

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission. / Sakurai, Masatoshi; Watanuki, Shintaro; Kato, Jun; Hashida, Risa; Yamane, Yusuke; Karigane, Daiki; Mitsuhashi, Takayuki; Murata, Mitsuru; Ueno, Hironori; Nakazato, Tomonori; Okamoto, Shinichiro; Mori, Takehiko.

In: Internal medicine (Tokyo, Japan), Vol. 57, No. 22, 15.11.2018, p. 3299-3302.

Research output: Contribution to journalArticle

Sakurai, Masatoshi ; Watanuki, Shintaro ; Kato, Jun ; Hashida, Risa ; Yamane, Yusuke ; Karigane, Daiki ; Mitsuhashi, Takayuki ; Murata, Mitsuru ; Ueno, Hironori ; Nakazato, Tomonori ; Okamoto, Shinichiro ; Mori, Takehiko. / Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission. In: Internal medicine (Tokyo, Japan). 2018 ; Vol. 57, No. 22. pp. 3299-3302.
@article{57824488c6364b7caf79e84ffa2ff630,
title = "Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission",
abstract = "The prognosis of acute promyelocytic leukemia (APL) has been improved by the combination of all-trans retinoic acid (ATRA) with chemotherapy. Nonetheless, relapse occurs in a certain proportion of patients, mostly within three to four years after treatment. We herein report a patient treated with ATRA and chemotherapy achieving remission who relapsed approximately 17 years after the treatment. A literature review identified 5 additional reported cases of APL relapse after more than 10 years. None of them presented with generally established risk factors for relapse, such as a high leukocyte count. The potential for late relapse of APL occurring more than 10 years after treatment should be recognized.",
keywords = "acute promyelocytic leukemia, all-trans retinoic acid, late relapse",
author = "Masatoshi Sakurai and Shintaro Watanuki and Jun Kato and Risa Hashida and Yusuke Yamane and Daiki Karigane and Takayuki Mitsuhashi and Mitsuru Murata and Hironori Ueno and Tomonori Nakazato and Shinichiro Okamoto and Takehiko Mori",
year = "2018",
month = "11",
day = "15",
doi = "10.2169/internalmedicine.0807-18",
language = "English",
volume = "57",
pages = "3299--3302",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "22",

}

TY - JOUR

T1 - Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission

AU - Sakurai, Masatoshi

AU - Watanuki, Shintaro

AU - Kato, Jun

AU - Hashida, Risa

AU - Yamane, Yusuke

AU - Karigane, Daiki

AU - Mitsuhashi, Takayuki

AU - Murata, Mitsuru

AU - Ueno, Hironori

AU - Nakazato, Tomonori

AU - Okamoto, Shinichiro

AU - Mori, Takehiko

PY - 2018/11/15

Y1 - 2018/11/15

N2 - The prognosis of acute promyelocytic leukemia (APL) has been improved by the combination of all-trans retinoic acid (ATRA) with chemotherapy. Nonetheless, relapse occurs in a certain proportion of patients, mostly within three to four years after treatment. We herein report a patient treated with ATRA and chemotherapy achieving remission who relapsed approximately 17 years after the treatment. A literature review identified 5 additional reported cases of APL relapse after more than 10 years. None of them presented with generally established risk factors for relapse, such as a high leukocyte count. The potential for late relapse of APL occurring more than 10 years after treatment should be recognized.

AB - The prognosis of acute promyelocytic leukemia (APL) has been improved by the combination of all-trans retinoic acid (ATRA) with chemotherapy. Nonetheless, relapse occurs in a certain proportion of patients, mostly within three to four years after treatment. We herein report a patient treated with ATRA and chemotherapy achieving remission who relapsed approximately 17 years after the treatment. A literature review identified 5 additional reported cases of APL relapse after more than 10 years. None of them presented with generally established risk factors for relapse, such as a high leukocyte count. The potential for late relapse of APL occurring more than 10 years after treatment should be recognized.

KW - acute promyelocytic leukemia

KW - all-trans retinoic acid

KW - late relapse

UR - http://www.scopus.com/inward/record.url?scp=85056659553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056659553&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.0807-18

DO - 10.2169/internalmedicine.0807-18

M3 - Article

C2 - 29984744

AN - SCOPUS:85056659553

VL - 57

SP - 3299

EP - 3302

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 22

ER -